Prof Alan Melcher is a Cancer Research UK Senior Clinical Research Fellow and Professor of Clinical Oncology and Biotherapy in the Leeds Institute of Molecular Medicine.  Having qualified from Oxford University, he trained in clinical oncology in Cardiff, London and Leeds.

Having completed a PhD at the Hammersmith Hospital in London, he continued post-doctoral research at the Mayo Clinic, Minnesota, USA before returning to the UK in 2000.

He currently combines a clinical practice treating melanoma with chemotherapy, radiotherapy and biotherapies, with a laboratory-based pre-clinical and clinical research programme focused on novel immune effector cells and oncolytic viruses for the treatment of cancer.

Please also read our full FAQ